产品中心您的位置:网站首页 > 产品中心 > 生物试剂 > 其他生化试剂 > 1038915-60-4MK-4827 (Niraparib)1038915-60-4

MK-4827 (Niraparib)1038915-60-4

更新时间:2024-09-24

访问量:817

厂商性质:经销商

生产地址:上海一基

简要描述:
MK-4827 (Niraparib)1038915-60-4
上海一基实业有限公司是主要从事配套试剂的生产和销售的企业,产品用途:科研实验,标准对照品研究中心代理的作为一种衡量标准

MK-4827 (Niraparib)1038915-60-4

MK4827 (Niraparib)
分子式:C19H20N4O    分子量:320.39
 
 
产品描述
MK-4827是选择性PARP1/2抑制剂,IC50为3.8 nM/2.1 nM, 作用于携带突变型BRCA-1和BRCA-2的癌细胞,具有强的作用活性。比作用于PARP3, V-PARP 和Tank1选择性高330倍以上。
靶点
PARP1
PARP2
       
IC50
3.8 nM
2.1 nM
       
体外研究
MK-4827 displays excellent PARP 1 and 2 inhibition with IC(50) = 3.8 and 2.1 nM, respectively, and in a whole cell assay, it inhibits PARP activity with EC(50) = 4 nM and inhibits proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC(50) in the 10-100 nM range.
体内研究
MK-4827 is well tolerated in vivo and demonstrates efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer.In addition, MK-4827 strongly enhances the effect of radiation on a variety of human tumor xenografts, both p53 wild type and p53 mutant. The enhancement of radiation response is observed in clinically relevant radiation-dose fractionation schedules. The therapeutic window during which time MK-4827 interacts with radiation lasts for several hours. These biological attributes make translation of this therapeutic combination treatment feasible for translation to the treatment of a variety of human cancers.
溶解性
可溶于DMSO
稳定性
2年 -20°C粉状,6月-80°C溶于DMSO

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7